古莹医学院基础医学长期从事白血病、淋巴瘤等恶性肿瘤发病机制、新型抗肿瘤靶标相关研究，在揭示肿瘤易感基因、白血病干细胞调控机制、以及新型特异性抗肿瘤药物方面取得突出成绩。个人简介:古莹博士浙江大学遗传学研究所/浙江大学附属第二医院双聘研究员、博士生导师浙江大学“百人计划”引进人才浙江省“千人计划”海外高层次引进人才国家“千人计划”（青年）引进人才教育背景2000-2007       浙江大学临床医学七年制（学士硕士学位连续培养）专业   临床医学硕士学位2007-2011       浙江大学医学院              内科学博士学位临床医学背景2003-2005       临床医学全科轮转         浙江大学附属邵逸夫医院2005-2007       临床医学内科学轮转     浙江大学附属第二医院2007-2010       血液内科                         浙江大学附属第二医院科研工作背景：2018 至今       浙江大学遗传学研究所/浙江大学附属第二医院任双聘研究员，百人计划研究员，博士生导师2011-2017       美国City of Hope国家医学中心   博士后研究方向：长期从事白血病、淋巴瘤等恶性肿瘤发病机制、新型抗肿瘤靶标相关研究，在揭示肿瘤易感基因、白血病干细胞调控机制、以及新型特异性抗肿瘤药物方面取得突出成绩。以第一作者身份在Cancer Cell、Blood、leukemia等肿瘤学、血液病学顶级期刊发表研究成果。2009-2010年度全国“百人会”英才奖获得者。教学与课程:医学遗传学研究与成果:在博士和博士后期间在国际知名杂志共发表高质量SCI研究论文11篇，其中第一作者SCI论文6篇，在2012-2017的5年里，在国际肿瘤学和血液病学顶级期刊共发表第一作者SCI研究论文5篇，包括《Cancer Cell》，《Blood》，《Leukemia》研究成果被《Cancer Discovery》和《Sicence Signaling》撰文特别点评。主要代表性成果如下：第一作者论文：Gu Y Zhang J Ma X Kim BW Wang H Li J Pan Y Xu Y Ding L Yang L Guo C Wu X Wu J Wu K Gan X Li G Li L Forman SJ Chan WC Xu R Huang W. Stabilization of the c-Myc protein by CAMKIIγ promotes T cell lymphoma. Cancer cell. 2017; 32 115-128. Gu Y Zhen W Zhang J Gan X Ma X Meng Z Chen T Lu X Wu Z Huang W Xu R. Aberrant activation of CaMKIIγ accelerates chronic myeloid leukemia blast crisis. Leukemia. 2016；30 (6) 1282-1289. Gu Y Chen T Meng Z Gan Y Xu X Lou G Li H Gan X Xu G Tang J  Zhou H  Huang L Zhang X Fang Y Wang K Huang W Xu R. CaMKII γ a critical regulator of leukemia stem/progenitor cells is a target of the natural product berbamine. Blood. 2012; 120: 4829-4839. Gu Y Zhou H Gan Y Zhang J Chen J Gan X Li H Zheng W Meng Z Ma X Wang X Xu X Xu G Lu X Liang Y Zhang X Lu X Huang W Xu R. Small-molecule induction of phospho-eIF4E sumoylation and degradation via targeting its phosphorylated serine 209 residue. Oncotarget. 2015 Apr 10. Gu Y Ting Z Qiu X Zhang X Gan X Fang Y Xu X Xu R. Linalool preferentially induces robust apoptosis of a variety of leukemia cells via upregulating p53 and cyclin-dependent kinase inhibitors. Toxicology. 2010 Jan 31; 268(1-2):19-24. Zhou H Zhang J Gu Y Gan X Gan Y Zheng W Kim BW Xu X Lu X Dong Q Zheng S Huang W Xu R. Identification of a novel RNA giant nuclear body in cancer cells. Oncotarget. 2015 Dec 15. 其他论文：Meng Z Ma X Du J Wang X He M Gu Y Zhang J Han W Fang Z Gan X Ness C Van Fu X Schones DE Xu R Huang W. CAMK2γ antagonizes mTORC1 activation during hepatocarcinogenesis. Oncogene. 2016 Nov 7. Ding L Sousa KM Jin L Dong B Kim BW Ramirez R Xiao Z Gu Y Yang Q Wang J Yu D Pigazzi A Schones D Yang L Moore D Wang Z Huang W. Vertical sleeve gastrectomy activates GPBAR‐1/TGR5 to sustain weight loss improve fatty liver and remit insulin resistance in mice. Hepatology. 2016; 64: 760-773. Han W Fu X Xie J Meng Z Gu Y Wang X Li L Pan H Huang W. miR-26a enhances autophagy to protect against ethanol-induced acute liver injury. Journal of Molecular Medicine. 2015 Apr 17. Chen T Meng Z Gan Y Wang X Gu Y Xu X Tang J Zhou H Zhang X Gan X Van Ness C Xu F Xu G Huang L Zhang X Fang Y Zheng S Jin J Huang W Xu R. The viral oncogene Np9 acts as a critical molecular switch for co-activating β-catenin ERK Akt and Notch1 and promoting the growth of human leukemia stem/progenitor cells. Leukemia. 2013 Jul; 27(7):1469-78. Xie J Ma T Gu Y Zhang X Qiu X Zhang L Xu R Yu Y. Berbamine derivatives: a novel class of compounds for anti-leukemia activity. Eur J Med Chem. 2009 Aug; 44(8):3293-8. 授权发明专利：徐荣臻，于晓方，俞永平，谢进文，古莹，张旭照 干小仙一类小檗胺衍生物及其盐的应用，2011.02.09中国，ZL200810060382.1工作研究项目:1. Toni Stephenson Lymphoma Cente Targeting CAMKIIg to treat T cell lymphoma by destabilizing c-Myc protein 2016-2017 主持 。2.The Nesvig Lymphoma Foundation，Targetting undruggable c-Myc By BBM2014-2015，副主持。3.National Institute of Health，NCI 1R01CA139158，Inverstigation of the role of nuclear receptor FXR in hepatocellular carcinoma2011-2016已结题，主要研究人员。4.National Institute of Health，NCI 2R01CA139158，MiRNAs in hepatocellular carcinoma development and treatment2017-2021在研，主要研究人员。5.国家自然科学基金面上项目，81270601，CaMKIIγ激酶调控慢性髓系白血病干细胞增殖和耐药分子机制，2013/01-2016/12已结题，主要研究人员。6.国家自然科学基金面上项目，81070420，新型白血病干细胞抑制剂小檗胺类化合物与其靶分子CaMK2G激酶相互作用分子机制研究，2011/01-2013/12已结题，主要研究人员。奖励荣誉:2003-2008 浙江大学优秀学生2009 全国“百人会英才奖”获得者2010 浙江大学突出社会工作奖2010 浙江大学争创优秀博士学位论文资助2011 浙江大学优秀博士毕业生2016 City of Hope Medical Center Postdoctoral Fellowship Travel Grant2017年入选中组部第十四批“青年千人计划”并受聘于浙江大学遗传学研究所/浙江大学附属第二医院任双聘研究员。发表论文:第一作者论文：Gu Y Zhang J Ma X Kim BW Wang H Li J Pan Y Xu Y Ding L Yang L Guo C Wu X Wu J Wu K Gan X Li G Li L Forman SJ Chan WC Xu R Huang W. Stabilization of the c-Myc protein by CAMKIIγ promotes T cell lymphoma. Cancer cell. 2017; 32 115-128. Gu Y Zhen W Zhang J Gan X Ma X Meng Z Chen T Lu X Wu Z Huang W Xu R. Aberrant activation of CaMKIIγ accelerates chronic myeloid leukemia blast crisis. Leukemia. 2016；30 (6) 1282-1289. Gu Y Chen T Meng Z Gan Y Xu X Lou G Li H Gan X Xu G Tang J  Zhou H  Huang L Zhang X Fang Y Wang K Huang W Xu R. CaMKII γ a critical regulator of leukemia stem/progenitor cells is a target of the natural product berbamine. Blood. 2012; 120: 4829-4839. Gu Y Zhou H Gan Y Zhang J Chen J Gan X Li H Zheng W Meng Z Ma X Wang X Xu X Xu G Lu X Liang Y Zhang X Lu X Huang W Xu R. Small-molecule induction of phospho-eIF4E sumoylation and degradation via targeting its phosphorylated serine 209 residue. Oncotarget. 2015 Apr 10. Gu Y Ting Z Qiu X Zhang X Gan X Fang Y Xu X Xu R. Linalool preferentially induces robust apoptosis of a variety of leukemia cells via upregulating p53 and cyclin-dependent kinase inhibitors. Toxicology. 2010 Jan 31; 268(1-2):19-24. Zhou H Zhang J Gu Y Gan X Gan Y Zheng W Kim BW Xu X Lu X Dong Q Zheng S Huang W Xu R. Identification of a novel RNA giant nuclear body in cancer cells. Oncotarget. 2015 Dec 15. 其他论文：Meng Z Ma X Du J Wang X He M Gu Y Zhang J Han W Fang Z Gan X Ness C Van Fu X Schones DE Xu R Huang W. CAMK2γ antagonizes mTORC1 activation during hepatocarcinogenesis. Oncogene. 2016 Nov 7. Ding L Sousa KM Jin L Dong B Kim BW Ramirez R Xiao Z Gu Y Yang Q Wang J Yu D Pigazzi A Schones D Yang L Moore D Wang Z Huang W. Vertical sleeve gastrectomy activates GPBAR‐1/TGR5 to sustain weight loss improve fatty liver and remit insulin resistance in mice. Hepatology. 2016; 64: 760-773.Han W Fu X Xie J Meng Z Gu Y Wang X Li L Pan H Huang W. miR-26a enhances autophagy to protect against ethanol-induced acute liver injury. Journal of Molecular Medicine. 2015 Apr 17. Chen T Meng Z Gan Y Wang X Gu Y Xu X Tang J Zhou H Zhang X Gan X Van Ness C Xu F Xu G Huang L Zhang X Fang Y Zheng S Jin J Huang W Xu R. The viral oncogene Np9 acts as a critical molecular switch for co-activating β-catenin ERK Akt and Notch1 and promoting the growth of human leukemia stem/progenitor cells. Leukemia. 2013 Jul; 27(7):1469-78. Xie J Ma T Gu Y Zhang X Qiu X Zhang L Xu R Yu Y. Berbamine derivatives: a novel class of compounds for anti-leukemia activity. Eur J Med Chem. 2009 Aug; 44(8):3293-8. 